Aptorum Group Limited - APM Sotuvning operatsion marjasi

Ommaviy kompaniya Aptorum Group (APM) logotipi

Aptorum Group Limited kompaniyasidagi kapitalning yuqori sifati robototexnika va infeksiya terapiyasi sohasidagi patentlarga asoslangan. Operatsion marja profili joriy daromadlilikni aks ettiradi, bunda 0.00 ushbu ko'rsatkichning joriy holatini tavsiflaydi. Keng qamrovli ishlanmalar portfeli guruhga litsenziyalash shartlarini belgilash imkonini beradi. Biroq, daromad generatorlarining yo'qligi ichki pul oqimi tanqisligi sababli kompaniyani tashqi moliyalashtirishga tayanishga majbur qilmoqda.

Aptorum Group Limited (APM): Sotuvning operatsion marjasi 04.07.2022dan 20.07.2026gacha

Aptorum (APM) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning fundamental baholanishi:APM, Aptorum Group Limited
Aptorum Group Ltd tayyor mahsulotlari

Biznesning xavfsizlik zaxirasini baholash operatsion marjaga asoslanadi, u qarzlar to'lovi va soliqlardan oldingi asosiy operatsiyalardan olingan foyda ulushini o'lchaydi hamda ichki resurslarni boshqarish samaradorligini belgilaydi. Operatsion marja ko'rsatkichi tahlili Aptorum Group Limited (APM) rahbariyatining biomeditsina loyihalari portfelini samarali monetizatsiya qilish va ishlanmalar AQSh klinik bosqichlariga o'tishi davomida moliyaviy barqarorlikni ta'minlash qobiliyatini tekshirish imkonini beradi.

Aptorum Group Limited raqobatchilari

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operatsion foyda normasi|Operatsion rentabellik Rallybio Corporation RLYB|LEXX: Operatsion foyda bo'yicha sotuv rentabelligi|PULM - Operatsion rentabellik|Operatsion foyda normasi PTHL (Pheton Holdings)|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.